essenti
viral
replic
highli
conserv
among
poxvirida
vaccinia
viru
ubiquitinlik
proteinas
ulp
attract
target
develop
smallpox
antivir
drug
time
proteinas
exemplifi
sever
interest
challeng
ration
drug
design
perspect
absenc
publish
xray
structur
built
detail
model
ligand
bind
site
pocket
base
except
high
structur
conserv
site
proteas
ulp
famili
accuraci
limit
model
assess
compar
analysi
avail
xray
structur
ulp
well
energi
base
conform
model
model
ligand
bind
site
use
perform
coval
dock
vl
comprehens
librari
avail
keton
aldehyd
compound
predict
ligand
inhibitor
proteinas
activ
confirm
biochem
assay
overal
hit
rate
experiment
result
valid
ligand
bind
model
provid
initi
lead
ration
optim
poxviru
proteinas
inhibitor
thu
fragment
predict
bind
prime
portion
activ
site
combin
fragment
nonprim
side
yield
compound
improv
activ
specif
abbrevi
proteas
inhibitor
ulp
ubiquitinlik
proteas
sar
structureact
relationship
vl
virtual
ligand
screen
icm
molecular
model
packag
molsoft
llc
proteas
compris
promin
class
target
ration
drug
design
human
proteas
implic
wide
rang
diseas
includ
cancer
cardiovascular
inflammatori
disord
ration
design
proteas
inhibitor
pi
also
prove
util
antivir
therapi
hepat
c
number
pi
target
import
diseas
agent
dengu
west
nile
herpesvirus
rhinovirus
sar
coronaviru
variou
stage
drug
develop
one
recent
identifi
viral
target
core
proteinas
play
critic
role
replic
vaccinia
orthopox
virus
variola
biowarfar
agent
smallpox
monkeypox
emerg
zoonot
biochem
studi
establish
cystein
proteinas
cleav
major
structur
membran
protein
viru
conserv
agx
motif
x
posit
prefer
small
residu
like
ala
ser
thr
highli
conserv
orthopox
virus
within
poxvirida
famili
share
amino
acid
ident
vaccinia
variola
monkeypox
orthologu
outsid
poxvirida
distant
homolog
ubiquitinlik
proteas
ulp
viral
eukaryot
origin
despit
sequenc
ident
low
viral
eukaryot
proteinas
share
similar
substrat
specif
ggx
agx
overal
fold
pattern
ident
catalyt
core
motif
hisglnci
like
ubiquitinlik
proteas
mutat
conserv
activ
site
residu
vaccinia
complet
abolish
catalyt
activ
function
import
conserv
among
poxvirida
establish
attract
target
design
antivir
time
proteinas
repres
sever
technic
challeng
ration
drug
design
first
simplist
peptid
cleavag
specif
agx
provid
littl
basi
build
select
peptidomimet
inhibitorsa
tradit
way
develop
initi
structur
activ
relationship
sar
proteas
target
lack
peptidomimet
sar
rel
low
throughput
avail
biochem
assay
make
larg
scale
virtual
ligand
screen
vl
small
molecul
librari
primari
option
gener
initi
hit
sar
second
xray
structur
proteinas
avail
low
level
sequenc
ident
structur
templat
pdb
case
would
allow
overal
predict
protein
fold
fortun
full
conserv
sever
key
residu
enclos
core
bind
site
ulp
includ
proteinas
suggest
possibl
accur
model
structur
target
site
compris
subpocket
detail
analysi
hypothet
model
studi
valid
accuraci
sever
differ
perspect
also
demonstr
applic
receptor
base
screen
inhibitor
third
challeng
relat
adequ
model
coval
natur
bind
inhibitor
proteas
activ
site
major
pi
clinic
clinic
develop
employ
type
nucleophil
warhead
bind
coval
proteas
catalyt
residu
success
warhead
among
cystein
proteas
inhibitor
moder
reactiv
keton
sever
studi
show
accur
model
pi
coval
bind
need
account
structur
chang
ligand
upon
reaction
catalyt
residu
requir
especi
relev
activ
site
enclos
tight
channel
demonstr
autom
implement
coval
dock
vl
procedur
framework
icm
molecular
model
packag
molsoft
llc
http
wwwmolsoftcom
studi
use
detail
structur
model
substrat
bind
site
perform
coval
dock
vl
comprehens
librari
avail
keton
compound
biochem
assay
confirm
inhibitor
proteinas
activ
predict
candid
hit
rate
experiment
result
valid
ligand
bind
model
provid
initi
lead
ration
optim
poxviru
proteinas
inhibitor
homolog
model
proteinas
domain
base
proteas
structur
templat
pdb
code
perform
use
icm
sequencestructur
align
buildmodel
algorithm
icm
sequencestructur
align
base
zega
sequenc
align
needleman
wunsch
algorithm
zero
gap
end
penalti
account
templat
structur
featur
posit
weight
adjust
surfac
access
secondari
structur
structur
model
subsequ
built
place
align
residu
polypeptid
chain
ideal
coval
geometri
onto
correspond
residu
structur
templat
conform
nonident
side
chain
loop
shorter
amino
acid
predict
use
energybas
optim
model
longer
loop
proteinas
locat
activ
site
expect
affect
conform
activ
site
predict
side
chain
residu
form
portion
substrat
bind
site
optim
addit
run
energi
minim
alaalaglys
peptid
substrat
substrat
conform
bind
site
infer
complex
substrat
heavi
atom
conserv
residu
tie
correspond
atom
structur
soft
harmon
tether
torsion
angl
substrat
torsion
angl
select
fifteen
side
chain
model
optim
respect
conform
energi
complex
energi
tether
three
independ
run
refin
procedur
perform
run
includ
mont
carlo
minim
step
icm
protein
health
tool
use
check
qualiti
refin
virtual
screen
perform
use
icm
fast
dock
procedur
icm
employ
montecarlo
minim
algorithm
find
optim
conform
flexibl
ligand
receptor
bind
side
repres
precalcul
potenti
grid
ligand
describ
intern
coordin
flexibl
torsion
variabl
best
conform
ligand
assign
icm
bind
score
take
account
follow
free
energi
term
van
der
waal
hydrogen
bond
poisson
electrostat
desolv
entropi
icm
vl
screen
procedur
take
less
min
per
compound
per
ghz
intel
xeon
processor
compar
benchmark
show
robust
perform
excel
accuraci
icm
dock
method
applic
standard
icm
vl
procedur
modifi
reflect
coval
bind
inhibitor
activ
site
illustr
fig
algorithm
keton
carbon
compound
convert
carbon
yield
two
differ
thioacyl
stereoisom
side
chain
remov
receptor
model
avoid
appar
steric
clash
instead
separ
three
atom
coval
bond
templat
creat
correspond
thioacyl
moieti
xray
structur
correspond
three
atom
ligand
tether
coval
bond
templat
flexibl
coval
bond
allow
use
harmon
tether
penalti
term
tether
penalti
calcul
dock
stage
includ
bind
score
calcul
modifi
stereoisom
dock
separ
activ
site
best
score
one
use
analysi
note
score
function
intent
take
account
chemic
energi
ligandthiol
coval
bond
format
see
discuss
quantit
invitro
cleavag
assay
develop
work
employ
measur
fluoresc
quench
time
depend
detect
proteolyt
cleavag
assay
use
extract
vaccinia
viru
vv
infect
bsc
cell
sourc
enzym
describ
previou
work
neg
control
use
extract
cell
transfect
plasmid
carri
inactiv
mutant
well
cell
extract
control
peptid
substrat
contain
defin
agt
cleavag
site
orthoaminobenzoyl
abz
fluoresc
group
conjug
amino
terminu
diaminopropionamid
dapdnp
quench
group
conjug
carboxi
terminu
anaspec
reaction
perform
room
temperatur
final
volum
contain
lm
peptid
substrat
abztnagtctvdap
dnp
anaspec
enzym
extract
buffer
mm
hepe
ph
mm
cacl
mm
edta
assay
reaction
carri
costar
blacksid
blackbottom
plate
background
read
taken
prior
addit
inhibitor
variou
concentr
compound
ad
reaction
measur
time
cours
fluoresc
measur
use
wallac
v
multilabel
htc
counter
perkin
elmer
excit
wavelength
nm
plate
read
nm
slope
enzym
plu
peptid
reaction
calcul
inhibit
compound
calcul
refer
slope
structur
model
analysi
ligand
bind
site
model
vaccinia
viru
protein
present
fig
built
yeast
cystein
proteinas
xray
structur
templat
describ
method
proteinas
closest
homologu
high
resolut
xray
structur
pdb
code
though
sequenc
homolog
weak
ident
amino
acid
sever
factor
make
possibl
gener
allatom
model
core
bind
pocket
correspond
subsit
conserv
key
contact
residu
activ
site
analysi
xray
structur
reveal
five
side
chain
proteinas
direct
contact
posit
substrat
fig
b
five
residu
core
bind
site
residu
shown
stick
color
atom
type
green
label
two
residu
activ
site
conserv
shown
stick
blue
label
correspond
residu
shown
red
stick
predict
overal
structur
proteinas
ribbon
color
accord
residu
ident
green
fulli
conserv
yellowsimilar
residu
substrat
shown
grey
ribbon
ctermin
glygli
residu
highlight
red
motif
whwqc
ident
nomenclatur
key
motif
includ
catalyt
side
chain
side
chain
togeth
backbon
amino
group
form
subtilisinlik
oxyanion
hole
well
side
chain
form
narrow
channel
substrat
core
substrat
contact
occur
backbon
atom
bind
pocket
sequencestructur
align
suggest
ident
core
substrat
contact
guarante
conserv
spatial
posit
whwqc
motif
residu
evid
toward
conserv
come
structur
comparison
xray
structur
three
closest
ulp
structur
homologu
sentrin
specif
proteas
well
adenoviru
core
proteas
advcp
fig
tabl
sequenc
ident
level
ulp
low
found
remark
preserv
coordin
whwqc
motif
residu
rmsd
addit
backbon
conform
residu
ulp
make
direct
backbon
side
chain
contact
substrat
site
highli
preserv
high
level
local
structur
similar
normal
observ
close
protein
homologu
point
function
signific
conserv
therefor
expect
structur
correspond
subsit
preserv
compar
accuraci
substrat
specif
defin
ag
x
ulp
gg
x
posit
x
prefer
small
residu
ala
ser
thr
interestingli
although
natur
substrat
gli
posit
analysi
xray
model
show
bind
site
easili
accommod
ala
pocket
creat
favor
van
der
waal
contact
thu
substrat
specif
practic
ident
posit
valid
model
bind
site
potenti
import
subsit
select
conform
adjac
subsit
also
predict
use
structur
model
ulp
site
highli
expos
solvent
control
three
residuesconserv
variabl
residu
posit
nomenclatur
eukaryot
ulp
variabl
posit
occupi
larg
residu
leu
met
replac
gli
shown
fig
blue
label
red
label
absenc
amino
acid
side
chain
posit
creat
addit
small
cleft
model
exploit
design
select
vs
ulp
conform
variabl
side
chain
close
proxim
activ
site
gli
infer
ulp
structur
ser
addit
conform
model
side
chain
refin
procedur
perform
model
bind
pocket
describ
method
compar
model
suggest
signific
deviat
core
bind
site
side
chain
conform
model
refin
perform
verifi
conform
five
residu
compat
adjac
residu
model
bind
peptid
substrat
result
show
good
converg
refin
procedur
model
three
independ
run
rmsd
exceed
heavi
atom
optim
residu
compar
icm
protein
health
tool
show
signific
clash
residu
model
five
core
residu
model
conform
within
rmsd
correspond
residu
nonconserv
side
chain
predict
form
hbond
side
chain
substrat
contact
describ
activ
site
repres
channellik
bind
pocket
volum
suitabl
ration
drug
design
core
bind
pocket
fulli
conserv
ulp
proteinas
nonconserv
residu
side
core
provid
basi
design
select
inhibitor
must
note
structur
analysi
strongli
support
model
ligandbind
pocket
model
consid
hypotheticaluntil
util
design
inhibitor
demonstr
candid
inhibitor
predict
use
dockingbas
vl
procedur
implement
icm
molecular
model
packag
molsoft
llc
standard
icm
dock
algorithm
modifi
reflect
chemic
chang
keton
ligand
upon
coval
bind
activ
site
describ
method
keton
compound
select
nonredund
librari
compound
avail
major
vendor
well
inhous
divers
librari
k
compound
keton
found
librari
total
k
compound
divid
four
group
base
chemic
reactiv
activ
site
thiol
aliphat
aldehyd
al
al
aromat
aldehyd
al
ar
aliphat
keton
ke
al
aromat
keton
ke
ar
expect
aliphat
aldehyd
repres
fewest
compound
druglik
databas
consid
reactiv
least
reactiv
aromat
keton
repres
avail
keton
compound
note
conjug
aromat
ring
usual
render
keton
aldehyd
chemic
stabl
though
reactiv
also
modul
electronwithdraw
substitut
ring
k
avail
keton
aldehyd
convert
correspond
thioacyl
intermedi
result
stereoisom
dock
proteinas
bind
site
model
bind
score
dock
compound
predict
vl
hit
identifi
icm
score
better
kjmol
dock
procedur
repeat
time
compound
result
run
compar
found
good
reproduc
dock
pose
overal
silico
result
least
hit
ident
independ
run
illustr
fig
highscor
compound
thioacyl
moieti
accur
fit
templat
anchor
predict
hit
averag
rmsd
thioacyl
templat
correspond
oc
atom
compound
estim
maximum
deviat
deproton
acyl
oxygen
ligand
also
found
properli
posit
oxyanion
hole
beyond
thioacyl
intermedi
core
varieti
specif
fragment
extend
prime
nonprim
site
identifi
figur
give
three
exampl
predict
inhibitor
differ
coverag
bind
pocket
first
candid
ligand
occupi
mainli
nonprim
subsit
methyl
group
extend
site
second
ligand
locat
primarili
subsit
fig
exampl
predict
bind
mode
three
activ
inhibitor
conserv
residu
bind
site
shown
green
stick
posit
thioacyl
templat
atom
shown
magenta
ball
inhibitor
shown
stick
yellow
carbon
nonprim
pocket
activ
site
b
prime
pocket
c
prime
nonprim
pocket
third
stretch
across
prime
nonprim
subsit
overal
cmpd
identifi
icm
score
better
kjmol
default
threshold
icm
vl
filter
compound
bad
chemic
properti
remov
redund
compound
select
set
compound
total
compound
receiv
biochem
test
predict
compound
test
biochem
assay
abil
inhibit
proteolyt
activ
assay
base
fluorescencequench
pair
probe
conjug
amino
carboxytermin
end
cleavag
peptid
respect
cleavag
peptid
remov
quench
group
monitor
increas
fluoresc
signal
baselin
candid
compound
initi
screen
biochem
assay
singl
concentr
lm
overal
result
primari
assay
present
tabl
give
account
compound
four
chemic
group
number
high
score
compound
experiment
hit
rate
total
inhibitor
identifi
yield
hit
rate
hit
rate
aromat
keton
lower
averag
group
compound
still
repres
major
hit
contrast
found
randomli
select
compound
suboptim
dock
score
icm
score
kjmol
none
shown
signific
activ
primari
assay
compound
found
inhibit
proteolyt
activ
lm
concentr
retest
determin
valu
result
secondari
assay
summar
fig
tabl
chemic
structur
compound
illustr
fig
compound
found
valu
lm
six
valu
lm
five
best
six
inhibitor
aromat
keton
warhead
favor
activityspecif
profil
discuss
coval
bind
ligand
proteas
nucleophil
activ
group
especi
thiol
remain
domin
strategi
drug
discoveri
note
cystein
proteas
inhibitor
clinic
preclin
develop
employ
coval
bind
thiol
candid
base
keton
warhead
case
ulp
strong
coval
bind
ligand
especi
import
compet
strong
substrat
bind
reinforc
larg
proteinprotein
interfac
see
fig
complex
substrat
recognit
interfac
decoupl
activ
site
amount
number
new
promis
warhead
introduc
recent
keton
still
consid
optim
due
moder
warhead
reactiv
proven
admetox
profil
good
chemic
tractabl
also
keton
among
warhead
suitabl
target
prime
nonprim
subsit
simultan
critic
optim
bind
specif
inhibitor
dock
studi
explicitli
account
coval
natur
ligandreceptor
bind
found
aspect
critic
accur
model
bind
standard
molecular
dock
procedur
reflect
structur
chang
ligand
flat
keton
carbon
convert
tetrahedr
carbon
initi
dock
result
indic
keton
moieti
fit
narrow
activ
site
channel
properli
posit
nucleophil
attack
without
induc
signific
conform
chang
bind
pocket
simul
proper
transit
state
keton
bind
modifi
coval
dock
procedur
similar
method
describ
implement
work
procedur
convert
keton
thioacyl
intermedi
link
activ
site
thiol
proteinas
flexibl
tether
hand
dock
score
procedur
account
chang
coval
energi
upon
ketonethiol
reaction
though
portion
dg
contribut
significantli
strong
ligand
bind
proteas
hard
properli
account
aspect
bind
model
moreov
higher
reactiv
also
contribut
nonspecif
interact
ligand
compromis
bioavail
safeti
profil
drug
therefor
believ
chemic
bond
contribut
consid
separ
conform
contribut
screen
proteas
inhibitor
differ
reactiv
four
type
keton
warhead
reflect
hit
rate
predict
candid
present
tabl
one
notic
predict
conform
bind
threshold
score
kjmol
reactiv
aldehyd
hit
rate
rate
drop
aliphat
keton
aromat
keton
latter
hit
rate
still
high
enough
least
reactiv
presum
ke
ar
ke
ar
ke
ar
al
ar
ke
ar
ke
al
ke
ar
ke
ar
ke
ar
ke
al
ke
al
ke
al
ke
ar
predict
icm
dock
score
posit
bind
pocket
catalyt
warhead
also
shown
chemic
structur
compound
present
tabl
specif
aromat
keton
compound
domin
list
inhibitor
strategi
ration
design
small
molecul
inhibitor
high
observ
hit
rate
predict
inhibitor
overal
success
valid
suggest
structur
model
show
applic
ration
drug
design
note
identifi
inhibitor
reach
specificitydefin
subsit
therefor
expect
select
ulp
proteinas
take
full
advantag
core
bind
pocket
achiev
select
suggest
synthesi
compound
combin
prime
nonprim
moieti
first
gener
hit
shown
tabl
sinc
bind
prime
nonprim
part
keton
virtual
independ
case
due
fix
posit
ketonethiol
bond
expect
addit
effect
bind
energi
though
fragment
base
design
strategi
requir
expens
denovo
synthesi
like
bring
gener
inhibitor
significantli
improv
affin
specif
perfect
structur
conserv
bind
site
ulp
famili
allow
gener
detail
model
vaccinia
viru
proteinas
bind
site
suitabl
dock
vl
modifi
icm
coval
dock
procedur
implement
reflect
coval
natur
keton
inhibitor
bind
activ
site
thiol
candid
inhibitor
select
work
avail
keton
aldehyd
biochem
assay
confirm
inhibit
candid
success
rate
activ
better
lm
result
provid
valid
model
coval
dock
procedur
well
extens
qsar
hit
optim
improv
activ
specif
achiev
ligand
combin
variou
prime
nonprim
moieti
identifi
work
